Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallRetrosynthesis plans a way to make a target molecule by reasoning backward toward simpler precursors. The same planning idea can be used for pharmaceutical, agrochemical, and flavour and fragrance targets, but a proposed route is a starting point for chemists to assess—not proof that the route works in the lab or is ready for production.
How does retrosynthesis turn a target into candidate routes?
A chemist starts with the structure of the molecule they want to make and works backward. They consider how bonds in the target might be disconnected and what simpler compounds could form it in a forward synthesis. Repeating that reasoning produces candidate pathways from the target toward potential starting materials.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Organic Chemistry | $125.24 | Buy on Amazon |
| 2 |
|
Organic Chemistry (MasteringChemistry) | $319.99 | Buy on Amazon |
| 3 |
|
Organic Chemistry as a Second Language: First Semester Topics | $76.48 | Buy on Amazon |
| 4 |
|
Organic Chemistry | $65.32 | Buy on Amazon |
| 5 |
|
Organic Chemistry I For Dummies (For Dummies (Math & Science)) | $11.48 | Buy on Amazon |
As an Amazon Associate I earn from qualifying purchases.
Computer-assisted planning systems apply reaction knowledge to propose possible transformations and pathways. The result is a plan to investigate: chemists still need to judge whether the chemistry is suitable, test it, and develop a process that meets the needs of the intended use. A plausible route on screen is not experimental evidence.
What does the cross-industry evaluation cover?
A Chemistry World event listing published September 15, 2026, and sponsored by Merck describes a presentation by Merck specialist Angelo Lanzilotto on a large-scale evaluation of SYNTHIA. It says the evaluation uses representative datasets spanning drug candidates, crop-protection ingredients, and fragrance compounds. The listing reports a starting library of 14 million commercially available chemicals and more than 120,000 expert-curated reaction rules.
Those figures describe what the sponsored listing says the system uses; they are not, by themselves, evidence of comparative performance. The listing does not provide numerical success rates or enough results to rank industries. It says the presentation addresses molecular complexity, chiral centres, synthetic accessibility, and routes of one, two, or three steps from commercial building blocks. These are topics described for the presentation, not verified success-rate results.
What changes across the three application areas?
The shared method is route planning, but the available evidence does not establish that the three sectors have the same production economics, regulatory constraints, volumes, or criteria for a successful route. The distinctions below reflect what the cited sources establish—not a complete account of each industry.
#1 Best Overall
| Application area | What the available sources establish | What they do not establish |
|---|---|---|
| Pharmaceuticals | The evaluation listing includes drug candidates. A 2017 review by Martin D. Eastgate, Michael A. Schmidt, and Keith R. Fandrick describes the process-chemistry goal as developing a commercially viable approach to a drug candidate. It discusses synthetic strategy, reaction development, and process development in relation to safer, more robust, and more efficient manufacturing. | There is no universal best route; nor does the cited review establish that its criteria transfer unchanged to agrochemicals or flavours and fragrances. |
| Agrochemicals | The listing includes crop-protection ingredients among its representative targets. | It does not provide sector-specific economics, regulatory comparisons, production volumes, or route success rates. |
| Flavours and fragrances | The listing includes fragrance compounds among its representative targets. | It does not provide sector-specific economics, regulatory comparisons, production volumes, or route success rates. |
How should a proposed route be judged?
A route that reaches commercially available building blocks may be easier to assess than one that ends at obscure or unavailable precursors, but availability in a planning library does not establish that a material can be sourced at the required price, quantity, or quality. Route length is only one consideration: a shorter path is not automatically better if its transformations are difficult, poorly selective, or unsupported by experimental evidence.
For a real decision, chemists need to examine the route in context. Useful questions include:
Rank #2
- Coverage: Does the tool support the target’s chemistry, and does it have relevant reaction knowledge?
- Starting materials: Can the proposed precursors actually be sourced, and are their cost and supply acceptable?
- Route design: How many steps are proposed, and does the route offer useful convergence without sacrificing yield, selectivity, or stereochemical control?
- Evidence: Which transformations have been experimentally demonstrated, and which remain predictions?
- Process suitability: Can the route be made robust and safe at the intended scale, with acceptable waste and commercial viability?
These are assessment criteria, not results of an apples-to-apples comparison among the three industries. In particular, a route-planning output does not establish scale-up performance, safety, cost, or supply.
What can readers take from the webinar listing?
It offers a cross-industry view of how one retrosynthesis system is being evaluated on targets from three sectors. Because the listing is sponsored by Merck and does not publish a results table or sector-level success rates, treat its dataset and system figures as attributed descriptions, not independent benchmark findings. The available details do not support a claim that SYNTHIA performs better in one sector, or that any proposed route is ready for manufacturing.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Where can a reader go deeper?
The Royal Society of Chemistry’s 2018 listing for Biocatalysis in Organic Synthesis: The Retrosynthesis Approach points to a Chapter 11 comparing biocatalytic routes and covering pharmaceutical and agrochemical targets. It may help readers explore that specific intersection, but it is not established as comprehensive coverage of flavours and fragrances.
Quick Recap
Best Value
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
